Latest Articles

Publication Date
How itching 'down there' could be sign of rare cancer & other signs to watch for - The Sun

How itching 'down there' could be sign of rare cancer & other signs to watch for The Sun

Published: Oct. 21, 2024, 6:30 p.m.
Pembrolizumab aids survival with high-risk endometrial cancer - Medical Xpress

Pembrolizumab aids survival with high-risk endometrial cancer Medical Xpress

Published: Oct. 21, 2024, 5:50 p.m.
Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More - OncLive

Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More OncLive

Published: Oct. 21, 2024, 5:04 p.m.
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer - HealthDay

Pembrolizumab Aids Survival With High-Risk Endometrial Cancer HealthDay

Published: Oct. 21, 2024, 3:35 p.m.
Apigenin as a Promising Agent for Enhancing Female Reproductive Function and Treating Associated Disorders.

Apigenin is an organic flavonoid abundant in some plants such as parsley, chamomile, or celery. Recently, it has been investigated for several of its pharmacological characteristics, such as its ability …

Published: Oct. 21, 2024, midnight
Contraceptives do not cause cancers or infertility, says doctor - The Standard

Contraceptives do not cause cancers or infertility, says doctor The Standard

Published: Oct. 20, 2024, 9 p.m.
80-year-old SoBo woman battles rare endometrial cancer - The Times of India

80-year-old SoBo woman battles rare endometrial cancer The Times of India

Published: Oct. 20, 2024, 9:35 a.m.
New research linking endometriosis to ovarian cancer risk could help with early detection - Pittsburgh Post-Gazette

New research linking endometriosis to ovarian cancer risk could help with early detection Pittsburgh Post-Gazette

Published: Oct. 20, 2024, 9:30 a.m.
Association between radiation therapy for primary endometrial cancer and risk of second primary malignancies: a retrospective cohort study - Nature.com

Association between radiation therapy for primary endometrial cancer and risk of second primary malignancies: a retrospective cohort study Nature.com

Published: Oct. 19, 2024, 7:34 p.m.
Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer - Nature.com

Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer Nature.com

Published: Oct. 19, 2024, 12:50 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!